跳至主要内容
临床试验/NCT00304473
NCT00304473已完成3 期

Fast Titration of Quetiapine Versus Conventional Titration in the Treatment of Schizophrenia/Schizoaffective Disorder: a Randomised, Parallel Group Open Trial

AstraZeneca1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2004年8月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
AstraZeneca
入组人数
40
试验地点
1
主要终点
Compare the safety and tolerability of a fast titration of quetiapine to the current titration approved by the regulatory authorities.

研究概览

简要总结

Assess the efficacy of a fast titration of quetiapine to the current titration approved by the regulatory authorities.

PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent, at least 18 years old, inpatients with relapse Schizophrenia all subtypes, and with a CGI (Clinical Global Impression) score >=4.

排除标准

  • Pregnancy or breast-feeding, patients treated with Clozapine within 28 days of randomization, patients with a known arrhythmia, any psychotic disorders not defined in the inclusion criteria.

结局指标

主要结局

Compare the safety and tolerability of a fast titration of quetiapine to the current titration approved by the regulatory authorities.

次要结局

  • Assess the efficacy of a fast titration of quetiapine to the current titration approved by the regulatory authorities.

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Fast Titration in the Treatment of Schizophrenia,... | 临床试验